ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C-Reference-Cited by-同舟云学术

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C

Published:2010-02-21 Issue:7287 Volume:464 Page:405-408
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Fellay Jacques,Thompson Alexander J.,Ge Dongliang,Gumbs Curtis E.,Urban Thomas J.,Shianna Kevin V.,Little Latasha D.,Qiu Ping,Bertelsen Arthur H.,Watson Mark,Warner Amelia,Muir Andrew J.,Brass Clifford,Albrecht Janice,Sulkowski Mark,McHutchison John G.,Goldstein David B.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature08825.pdf

Reference27 articles.

1. Lavanchy, D. The global burden of hepatitis. Liver Int. 29, 74–81 (2009)

2. McHutchison, J. G. et al. Peginterferon α-2b or α-2a with ribavirin for treatment of hepatitis C infection. N. Engl. J. Med. 361, 580–593 (2009)

3. Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399–401 (2009)

4. van Wijk, R. et al. HK Utrecht: missense mutation in the active site of human hexokinase associated with hexokinase deficiency and severe nonspherocytic hemolytic anemia. Blood 101, 345–347 (2003)

5. de Vooght, K. M. K., van Solinge, W. W., van Wesel, A. C., Kersting, S. & van Wijk, R. First mutation in the red blood cell-specific promoter of hexokinase combined with a novel missense mutation causes hexokinase deficiency and mild chronic hemolysis. Haematologica 94, 1203–1210 (2009)

Cited by 411 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapy;BMC Infectious Diseases;2024-03-11

2. The deleterious effects of sofosbuvir and ribavirin (antiviral drugs against hepatitis C virus) on different body systems in male albino rats regarding reproductive, hematological, biochemical, hepatic, and renal profiles and histopathological changes;Scientific Reports;2024-03-07

3. An ITPA Enzyme with Improved Substrate Selectivity;The Protein Journal;2023-12-08

4. Associations of ITPA gene polymorphisms with outcomes among chronic hepatitis C patients treated with Peg-interferon/ribavirin: A 5-year follow-up study;Medicine;2023-10-27

5. Inosine triphosphate pyrophosphatase: A guardian of the cellular nucleotide pool and potential mediator of RNA function;WIREs RNA;2023-04-24